Anders P. Wiklund, Chairman of the Board of Directors of IRRAS AB, has passed away after a period of illness. Anders P. Wiklund has been a board member of IRRAS since 2016 and the Chairman of the Board of Directors since 2017. Existing board member Marios Fotiadis will become the new Chairman and will serve in this capacity until the next general meeting of IRRAS.
“We are extremely sad that Anders has passed away. Anders was an incredible human being, a legendary healthcare professional with wonderful insights and vision that has been immensely helpful to our company. He has been a great mentor to me and the management during the years we have worked together. His long operational experience and strategic understanding have been enormously valuable as we built a legacy company in neurocritical care. My thoughts are with Anders’ family and relatives. He will forever be in our thoughts and hearts,” said Kleanthis G. Xanthopoulos, CEO of IRRAS.
IRRAS is a global medical care company focused on delivering innovative medical solutions to improve the lives of critically ill patients. IRRAS designs, develops, and commercializes neurocritical care products that transform patient outcomes and decrease the overall cost of care by addressing complications associated with current treatment methodologies. IRRAS markets and sells its comprehensive, innovative IRRAflow and Hummingbird ICP Monitoring product lines to hospitals worldwide through its direct sales organization in the United States and select European countries as well as an international network of distribution partners.
IRRAS maintains its headquarters in Stockholm, Sweden, with corporate offices in Munich, Germany, and San Diego, California, USA. For more information, please visit www.irras.com.
IRRAS is listed on Nasdaq Stockholm (ticker: IRRAS).
For more information, please contact:
Kleanthis G. Xanthopoulos, Ph.D.
The information was released for public disclosure, through the agency of the contact person above, on August 18, 2020 at 21:45 (CET).